Patent · US Active

Anti-tumor endothelial marker-1 (TEM1) antibody variants and uses thereof

US9783610B2 · kind B2 · utility

0Cited by

37References

4Claims

0Family size

Assignee

The Trustees of the University of Pennsylvania · US

Inventors

George Coukos · Lansdowne, US
Chunsheng Li · Havertown, US

Key dates

Filing date	Mar 15, 2013
Grant date	Oct 10, 2017
Priority date	—
Expiry date	Mar 15, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to variants of an antibody or antigen-binding fragment that binds specifically to an endosialin tumor endothelial marker 1 (TEM1), and prophylactic, diagnostic, and therapeutic methods using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.